IL33 and neoplasm: Genetic overexpression of IL-33 led to increased tumour burden and expression of Il4, Il5 and Il13 in Th2 cells, and this correlated with increased tumorigenesis in the Apcmin/+ mice (91), while genetic deficiency of IL-33 reduced overall tumour Il4 and Il13 expression (84).